Related Experiment Video
Updated: May 28, 2026

Manual Muscle Testing: A Method of Measuring Extremity Muscle Strength Applied to Critically Ill Patients
Published on: April 12, 2011
ICU-Acquired Weakness: An Unsolved Clinical Problem: A Narrative Review
Meghan Spoeri1, Rebecca Shamberg1, Nia Moragne1
1Department of Anesthesiology, Critical Care & Pain Medicine, Endeavor Health, Evanston, IL 60201, USA.
Intensive care unit-acquired weakness (ICUAW) causes severe muscle and nerve damage in critically ill patients. Early diagnosis and new research are crucial for better outcomes and reduced long-term disability.
Area of Science:
- Critical care medicine
- Neurology
- Physical rehabilitation
Background:
- Intensive care unit-acquired weakness (ICUAW) is a frequent and severe complication in critically ill patients.
- It involves skeletal muscle weakness (myopathy), peripheral nerve dysfunction (polyneuropathy), or both (polyneuromyopathy).
- Risk factors include prolonged ventilation, immobilization, and critical illness severity.
Purpose of the Study:
- To review current diagnostic tools, management strategies, and prognosis for ICUAW.
- To highlight challenges in diagnosis and the need for improved methods.
- To identify emerging research areas for earlier detection and intervention.
Main Methods:
- Review of existing literature on ICUAW diagnosis, risk factors, and management.
- Discussion of current assessment tools like MRC-SS and handgrip dynamometry.
- Exploration of limitations of current diagnostic methods and potential of new approaches.
Main Results:
- ICUAW diagnosis is often delayed and relies on excluding other causes.
- Current assessment tools (MRC-SS, dynamometry) are often impractical for severely ill patients.
- Effective diagnostic tools and understanding of pathophysiology are lacking, limiting management to rehabilitation.
Conclusions:
- ICUAW significantly increases morbidity and mortality, leading to long-term disability.
- There is an urgent need for reliable, early diagnostic methods for ICUAW.
- Future research in biomarkers and risk prediction models holds promise for improved patient outcomes.
Related Concept Videos
Myasthenia Gravis ll: Pathophysiology
Spinal Cord Injury ll: Pathophysiology
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury I: Introduction
